Medicofarma Biotech (MDB.WA) Stock Price
Medicofarma Biotech Price
Revenue at Medicofarma Biotech has contracted by 11.8% per year over the past 9 years to 1.22 M PLN. Earnings per share have grown at 29.1% per year over the last 2 years. Medicofarma Biotech's net margin stands at -187.8%, down from -25.2% several years earlier.
Medicofarma Biotech stock price
Medicofarma Biotech business model & stock analysis
Frequently asked questions about Medicofarma Biotech
Converted at the current exchange rate, the Medicofarma Biotech share trades at 0.09 EUR (0.40 PLN).
The revenue cannot currently be calculated for Medicofarma Biotech.
The profit cannot currently be calculated for Medicofarma Biotech.
The P/E ratio cannot be calculated for Medicofarma Biotech at the moment.
The P/S cannot be calculated for Medicofarma Biotech currently.
The Eulerpool Quality Score for Medicofarma Biotech is 1/10.
The ISIN of Medicofarma Biotech is PLINBOK00010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medicofarma Biotech is MDB.WA. The ticker symbol is used to trade Medicofarma Biotech shares on the stock exchange.
Medicofarma Biotech stock
Medicofarma Biotech Peer Group
Medicofarma Biotech FIGI
All fundamentals and in-depth analysis of Medicofarma Biotech
Our stock analysis for Medicofarma Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medicofarma Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.